AstraZeneca Pharma India Ltd. — Board/Management Information 2019

Mar 14, 2019

March 14, 2019

The Manager - Listing BSE limited, 1⁵¹Floor, New Trading Ring Rotunda Buiding, P J Towers, Dalal Street, Fort, Mumbai 400001

The Manager - Listing Nat ional Stock Exchange of India ltd. Exchange plaza, 5^{1 h}Floor, Plot No.C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir(s),

Sub: Appointment of M s. Sarah Wang as an Additional Director

Ref: Scrip Code - BSE: 506820 / NSE: ASTRAZEN

This is to inform you that on March 13, 2019, the Board of the Directors of the Company has appointed Ms. Weiying Sa rah Wang (DIN: 08369289) as an Addit ional Director (Non-Executive) on the Board of Directors of the Company.

A brief profile of Ms. Sarah Wang is enclosed herewith.

Ms. Sarah Wang is not related to any other director of the Company.

We request you to please take the same on record.

Thanking you,

Pratap Rudra Company Secretary & Legal Counsel

CORPORATE & REGD. OFFICE AstraZeneca Pharma India Ltd. P. B. No. 4525, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bangalore- 560 045, INDIA

TEL : +91 80 6774 8000 FAX : +91 80 6774 8857

CIN : L24231KA1979PLC003563

WEB : www.astrazeneca.com/india

FACTORY 12th Mile on Bellary Road Venkatala, Kattigenahalli Village Yelahanka Bangalore - 560 063 INDIA

TEL : +91 80 6774 9000

FAX : +91 80 2846 2208 +91 80 6774 9628 Brief Profile of Ms. Sarah Wang

Ms. Sarah Wang is the Deputy General Counsel, International & Japan in the AstraZeneca group.

In her role she handles a wide spectrum of legal mattes including risk control, litigation, investigations, business transactions and IP matters.

She has strong educational background including LL.B, LL.M and J.D.